Related Experiment Video
Updated: Jun 28, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
[Glaucoma and age-related macular degeneration intricacy]
1Institut du Glaucome, Fondation Hôpital Saint-Joseph, 185 rue Raymond-Losserand, 75674 Paris cedex 14, France.
Abstract:
Age-related macular degeneration (AMD) is the leading cause of legal blindness among the elderly in Western nations. Age is also a well-known and well-evidenced risk factor for glaucoma. With increasing longevity and the rising prevalence of older people around the world, more and more patients will have glaucoma and AMD. Clinical evaluation of these patients still poses problems for clinicians. It is very important to order the right tests at the right time to distinguish glaucomatous defects from those caused by retinal lesions, because appropriate therapy has a beneficial effect on slowing or halting damage.
Related Concept Videos
Glaucoma: Overview
Photoreceptors and Visual Pathways
Diabetic Retinopathy
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

